LB LB BIOGALENIC
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 16 Aug 2023)
What this means for you
Registered since 23 Jan 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87279993
- Registration number
- 5383725
- Mark type
- Word mark
- Filed
- 23 Dec 2016
- Published for opposition
- 07 Nov 2017
- Registered
- 23 Jan 2018
- Attorney of record
- Marina Bentata Skornicki
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of water electrolyte imbalance, infections in surgical procedures, secretory and bleeding surgical management, chronic kidney disease, nutritional deficiency in intensive care and post-surgical treatments; veterinary preparations for the treatment of water electrolyte imbalance, infections in surgical procedures, secretory and bleeding surgical management, chronic kidney disease, nutritional deficiency in intensive care and post-surgical treatments
Owner
- LABORATORIOS BIOGALENIC, SOCIEDAD ANONIMA DE CAPITAL VARIABLE, San Salvador, SV
- LABORATORIOS BIOGALENIC, SOCIEDAD ANONIMA DE CAPITAL VARIABLE, San Salvador, SV
- LABORATORIOS BIOGALENIC, SOCIEDAD ANONIMA DE CAPITAL VARIABLE, San Salvador, SV
Prosecution history
- 16 Aug 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 16 Aug 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 16 Aug 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 17 Feb 2023 — TEAS SECTION 8 & 15 RECEIVED
- 23 Jan 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 23 Jan 2018 — REGISTERED-PRINCIPAL REGISTER
- 07 Nov 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Nov 2017 — PUBLISHED FOR OPPOSITION
- 18 Oct 2017 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 05 Oct 2017 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 02 Oct 2017 — ASSIGNED TO LIE
- 20 Sept 2017 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Sept 2017 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 19 Sept 2017 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 19 Sept 2017 — TEAS RESPONSE TO OFFICE ACTION RECEIVED